Vitaspring Biomedical VSBC
OTC VSBC
$0.01 +0.00 (+0.00%)
At close: Sep 28, 2026 · 4:00 PM EDT

Vitaspring Biomedical (VSBC) Current Deferred Tax Assets (2021)

Updated

Vitaspring Biomedical (VSBC) posted Current Deferred Tax Assets of $56,252 for fiscal Q1 2022 (quarter ended Apr 30, 2021).

Analysis

Vitaspring Biomedical (VSBC) Current Deferred Tax Assets (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Vitaspring Biomedical 2.07 Mn 2.04 Mn -
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2021 56,252.00
API Access

Vitaspring Biomedical Current Deferred Tax Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-tax-assets&ticker=VSBC&period=max&api_key=YOUR_API_KEY